Cargando…
Pulmonary Manifestations of Hematological Malignancies: Focus on Pulmonary Chronic Graft-Versus Host Disease
Advances in the management of patients in terms of the diagnosis and treatment of hematologic malignancies and treatment-related complications, especially infectious complications, have increased survival time. However, more than half of the patients treated for hematologic malignancies will develop...
Autores principales: | Chagnon, Karine, Schlemmer, Frédéric, Meignin, Véronique, Bergeron, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120310/ http://dx.doi.org/10.1007/978-1-4471-2401-6_32 |
Ejemplares similares
-
Predictors of Hematologic Malignancy Relapse in Patients with Advanced Chronic Graft-versus-Host Disease
por: Ruben, Claire L., et al.
Publicado: (2021) -
Clinical Characterization and Cytokine Profile of Fatigue in Hematologic Malignancy Patients with Chronic Graft-Versus-Host Disease
por: Goklemez, Sencer, et al.
Publicado: (2021) -
Hematological manifestations in patients newly diagnosed with pulmonary tuberculosis
por: Batool, Yasmeen, et al.
Publicado: (2022) -
Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022) -
A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022)